image
Editas Medicine, Inc. EDIT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.56
3.91 %
$ 131 M
Market Cap
-0.46
P/E
BALANCE SHEET
342 M ASSETS
-31.57%
Growth Rates
1Year -31.57%
3Years -20.41%
5Years -7.66%
7Years -1.26%
10Years 39.56%
207 M LIABILITIES
38.16%
Growth Rates
1Year 38.16%
3Years 18.74%
5Years -3.40%
7Years 3.30%
10Years 22.39%
134 M EQUITY
-61.54%
Growth Rates
1Year -61.54%
3Years -37.64%
5Years -12.54%
7Years -6.07%
10Years 26.84%
BALANCE SHEET DECOMPOSITION
Balance Sheet Editas Medicine, Inc.
image
Current Assets 289 M
Cash & Short-Term Investments 270 M
Receivables 16.3 M
Other Current Assets 3.14 M
Non-Current Assets 52.3 M
Long-Term Investments 0
PP&E 47.1 M
Other Non-Current Assets 5.22 M
79.02 %4.76 %13.77 %Total Assets$341.6m
Current Liabilities 77.2 M
Accounts Payable 5.49 M
Short-Term Debt 14.7 M
Other Current Liabilities 57.1 M
Non-Current Liabilities 130 M
Long-Term Debt 20.4 M
Other Non-Current Liabilities 110 M
7.07 %27.53 %9.83 %52.92 %Total Liabilities$207.3m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 131.5 123.7 141.5 203.5 139.7 238.2 134.8 146.6 185.3 143.2 10.6 2.0
Short Term Investments 138.4 199.5 202.8 296.3 262.4 219.0 234.2 182.5 0 0 0 0
Receivables 16.3 10.2 5.1 0.3 6.0 0.4 30 K 0.7 88 K 1.0 0 0
Inventory 0 0 (93.1) (120.1) (109.7) 0 2.9 1.9 1.7 0.8 0 0
Other Current Assets 3.1 7.5 7.3 14.4 21.9 12.6 5.8 2.4 1.8 0.8 93 K 77 K
Total Current Assets 289.3 340.8 356.8 507.3 419.1 463.8 374.8 332.2 187.2 145.0 10.7 2.1
PP&E 47.1 45.7 59.2 43.3 39.1 39.6 40.2 39.4 40.4 2.1 1.1 52 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 104.0 93.1 120.1 109.7 5.3 5.4 1.6 1.6 0 0 0
Other Long Term Assets 5.2 8.6 5.3 6.8 4.7 0.1 0 0 0 2.2 0.4 0.3
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 341.6 499.2 514.3 677.5 572.6 508.9 420.4 373.3 229.2 149.4 12.2 2.5
LIABILITIES
Accounts Payable 5.5 8.3 9.5 5.0 6.4 5.8 5.3 4.0 4.6 1.4 2.6 0.4
Short Term Debt 14.7 24.2 22.2 20.6 13.6 11.6 0 7.5 10.0 0 67 K 0
Other Current Liabilities 50.9 34.6 20.2 9.9 17.2 19.0 14.9 11.9 18.4 5.5 3.5 1.7
Total Current Liabilities 77.2 63.2 60.1 46.9 58.2 60.0 35.9 36.7 33.1 6.9 6.2 2.1
Long Term Debt 20.4 24.4 32.9 16.1 19.3 23.3 32.4 33.4 35.1 199.9 0.3 2.1
Deferred Tax Income 0 0 (60.7) (60.9) 0 (23.3) 0 0 0.4 0.3 0 0
Other Liabilities 109.7 1.8 0 0 27.5 1 K 0.3 0.3 0.4 0.3 21.0 5 K
Total Liabilities 207.3 150.1 153.6 123.8 179.0 246.4 184.2 165.2 94.6 232.5 27.5 4.2
EQUITY
Common Stock 8 K 8 K 7 K 7 K 6 K 5 K 5 K 4 K 4 K 0 0 0
Retained Earnings (1 468.4) (1 231.3) (1 078.1) (857.7) (665.2) (549.2) (416.3) (305.9) (185.5) (88.3) (15.4) (1.8)
Other Accumulative Comprehensive Income/Loss 0.3 0.2 (3.6) (0.5) 46 K 0.1 29 K 76 K (229.2) 0 0 0
Total Equity 134.3 349.1 360.7 553.6 393.6 262.4 236.2 208.1 134.6 (83.1) (15.3) (1.8)
Total Liabilities and Equity 341.6 499.2 514.3 677.5 572.6 508.9 420.4 373.3 229.2 149.4 12.2 2.5
SHARES OUTSTANDING
Common Shares Outstanding 82.3 76.0 68.7 67.6 58.6 50.0 47.1 40.3 32.2 35.7 15.4 0.3